Opioid Dependence
Pipeline by Development Stage
Competitive Landscape
14 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 21 trials with date data
Clinical Trials (21)
Total enrollment: 5,241 patients across 21 trials
XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept
Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population
A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal
Study to Assess Longer-term Opioid Medication Effectiveness (SALOME)
The German Project of Heroin Assisted Treatment of Opiate Dependent Patients
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse
A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.
INDV-2000 First in Human
Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB
The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care
Intervening With Opioid-Dependent MothersMothers and Infants
Probuphine Innovations for Clinical Effectiveness (PRINCE)
Pilot Test of a Community-based Buprenorphine Treatment Intervention
ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry
Completion of OST - a Prospective Study
Starting Treatment With Agonist Replacement Therapies Follow-up Study
Related Jobs
Rotational Key Account Manager, Harrisburg, PA
Regional Business Specialist, NJ / NYC / LI
Key Account Manager, Torrance, CA
Key Account Manager, Wilmington, DE
Key Account Manager, Central Jersey
Regional Business Specialist, MT / MN / ND
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.